Literature DB >> 17853300

Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).

Sîan M J Hemmings1, Craig J Kinnear, Lize Van der Merwe, Christine Lochner, Valerie A Corfield, Johanna C Moolman-Smook, Dan J Stein.   

Abstract

Although evidence from family studies suggest that genetic factors play an important role in mediating obsessive-compulsive disorder (OCD), results from genetic case-control association analyses have been inconsistent. Discrepant findings may be attributed to the lack of phenotypic resolution, and population stratification. The aim of the present study was to investigate the role that the val66met variant within the gene encoding brain-derived neurotrophic factor (BDNF) may play in mediating the development of selected OCD subtypes accounting for the aforementioned confounding factors. One hundred and twelve OCD subjects and 140 controls were selected from the South African Afrikaner population. A significant association was observed in the male subgroup, with the met66 allele implicated as the risk allele in the development of OCD. This allele was also found to be associated with an earlier age at onset of OCD in males. On the other hand, the val66val genotype was associated with more severe OCD in the female population. No evidence of population stratification was observed in Afrikaner control subjects. These preliminary results point towards genetically distinct characteristics of OCD mediated by dysfunctions in BDNF. The present investigation forms part of ongoing research to elucidate the genetic components involved in the aetiology of OCD and OCD-related characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17853300     DOI: 10.1080/15622970701245003

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  17 in total

1.  A CASE OF PERIPARTUM OBSESSIVE-COMPULSIVE DISORDER: The Potential Role of Corticosteroids, Gonadal Steroids, and the Neuropeptide Oxytocin in its Pathogenesis.

Authors:  David R Spiegel; Kathyrn Sommese; Anastasia Turenkov; Niels Naimon
Journal:  Innov Clin Neurosci       Date:  2019-05-01

Review 2.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

3.  BDNF and LTP-/LTD-like plasticity of the primary motor cortex in Gilles de la Tourette syndrome.

Authors:  L Marsili; A Suppa; F Di Stasio; D Belvisi; N Upadhyay; I Berardelli; M Pasquini; S Petrucci; M Ginevrino; G Fabbrini; F Cardona; G Defazio; A Berardelli
Journal:  Exp Brain Res       Date:  2016-11-30       Impact factor: 1.972

4.  Animal Models for OCD Research.

Authors:  Brittany L Chamberlain; Susanne E Ahmari
Journal:  Curr Top Behav Neurosci       Date:  2021

5.  Symptom dimensions in OCD: item-level factor analysis and heritability estimates.

Authors:  Hilga Katerberg; Kevin L Delucchi; S Evelyn Stewart; Christine Lochner; Damiaan A J P Denys; Denise E Stack; J Michael Andresen; J E Grant; Suck W Kim; Kyle A Williams; Johan A den Boer; Anton J L M van Balkom; Johannes H Smit; Patricia van Oppen; Annemiek Polman; Michael A Jenike; Dan J Stein; Carol A Mathews; Danielle C Cath
Journal:  Behav Genet       Date:  2010-04-02       Impact factor: 2.805

6.  The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome.

Authors:  B Ben Zeev; A Bebbington; G Ho; H Leonard; N de Klerk; E Gak; M Vecsler; M Vecksler; J Christodoulou
Journal:  Neurology       Date:  2009-04-07       Impact factor: 9.910

Review 7.  Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.

Authors:  Li Wang; Helen B Simpson; Stephanie C Dulawa
Journal:  Behav Pharmacol       Date:  2009-03       Impact factor: 2.293

8.  The Genetics of Obsessive-Compulsive Disorder.

Authors:  Michael H Bloch; Christopher Pittenger
Journal:  Curr Psychiatry Rev       Date:  2010-05-01

9.  Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis.

Authors:  Sharain Suliman; Sian M J Hemmings; Soraya Seedat
Journal:  Front Integr Neurosci       Date:  2013-07-29

10.  Population genetic study of the brain-derived neurotrophic factor (BDNF) gene.

Authors:  T L Petryshen; P C Sabeti; K A Aldinger; B Fry; J B Fan; S F Schaffner; S G Waggoner; A R Tahl; P Sklar
Journal:  Mol Psychiatry       Date:  2009-03-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.